Immunopathogenesis of vaccine-enhanced RSV disease. (Q40595357)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587806%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Immunopathogenesis of vaccine-enhanced RSV disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587806%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587806%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Fiona Jane Culley

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587806%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

W Olszewska

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587806%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587806%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587806%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

20 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587806%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

S27-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587806%20AND%20SRC:MED&resulttype=core&format=json

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Distinct types of lung disease caused by functional subsets of antiviral T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Cell-mediated immune response to respiratory syncytial virus infection: Relationship to the development of reactive airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

Immunity and immunopathology to respiratory syncytial virus. The mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900301-2

7 January 2021

10.1016/S0264-410X(01)00301-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587806%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference